Larvol Delta - Pharmacokinetics-of-Oral-Letermovir-in-Adults-With-EndStage-Kidney-Disease-With-or-Without-Haemodialysis

Prevymis (letermovir) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT07101055

Aug 5, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next